Medicine guide

EPCLUSA 400 mg/

As listed in the register: EPCLUSA 400 mg/100 mg, comprimé pelliculé

100 mg + 400 mg · comprimé pelliculé

  • Prescription only
Active substance
Velpatasvir + Sofosbuvir
Made by
GILEAD SCIENCES IRELAND UC (IRLANDE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byGILEAD SCIENCES IRELAND UC (IRLANDE)
Active substanceVelpatasvir + Sofosbuvir
Strength100 mg + 400 mg
Formcomprimé pelliculé
Routeorale
Dispensing (as stated by the register)liste I
MarketedYes, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/16/1116
Name in the registerEPCLUSA 400 mg/100 mg, comprimé pelliculé
Packs1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 28 comprimé(s)
CIS63434686
CIP133400930067314

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.